Activated phosphoinositide 3-kinase δ syndrome (APDS): Challenges in diagnosis, management and recent advances in treatment
Activated phosphoinositide 3-kinase δ syndrome (APDS): Challenges in diagnosis, management and recent advances in treatment
Introduction from Chair
Anna Sediva
APDS: diagnosis and management
Anita Chandra
Scientific exchange session: Phase 3 safety and efficacy data of leniolisib, an investigational treatment for APDS
Virgil A. Dalm